Molecule Information
General Information of the Molecule (ID: Mol02221)
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Investigative Drug(s)
1 drug(s) in total
Lipopolysaccharide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Neonatal pneumonia | [1] | |||
Resistant Disease | Neonatal pneumonia [ICD-11: KB24.0] | |||
Resistant Drug | Lipopolysaccharide | |||
Molecule Alteration | Down-regulation | Interaction |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | WI-38 cells | Fetal lung | Homo sapiens (Human) | CVCL_0579 |
Experiment for Molecule Alteration |
qRT-PCR; Western bloting analysis; Enzyme-linked immunosorbent assay; Mimic | |||
Experiment for Drug Resistance |
CCK8 assay; Flow cytometry assay | |||
Mechanism Description | Long noncoding RNA MIAT2 alleviates lipopolysaccharide-induced inflammatory damage in WI-38 cells by sponging microRNA-15. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.